61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Baxter International Inc
Closed
Sector Healthcare
32.59 -1.54
Overview
Share price change
24h
Min
32.5
Max
32.76
Income | 454M 140M |
|---|---|
Sales | 40M 3.9B |
P/E Sector Avg | 84.04 59.362 |
EPS | 0.8 |
Dividend yield | 3.055 |
Profit margin | 3.636 |
EBITDA | 215M 350M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +8.34 upside |
Dividend yield Sector Avg | 3.06% 2.35% |
|---|---|
Next Earnings | 13 Feb 2025 |
Next Dividend date | 31 Mar 2025 |
Next Ex Dividend date | 27 Feb 2025 |
Market Cap | 1.3B 17B |
|---|---|
Previous open | 34.13 |
Previous close | 32.59 |
News Sentiment
By Acuity
57%
43%
328 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Bullish Evidence
Baxter International Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Baxter International Inc Forecast
Price Target
By TipRanks
8.34% upside
12 Months Forecast
Average 35.86 USD 8.34%
High 42 USD
Low 30 USD
Based on 7 Wall Street analysts offering 12 month price targets forBaxter International Inc - Dist in the last 3 months.
Sentiment
By Acuity
328 / 393 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Baxter International Inc
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.
